Anti-LCLAT1 monoclonal antibody

Pre-made anti-LCLAT1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LCLAT1/LCLAT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1072-Ab-1/ GM-Tg-hg-IP1072-Ab-2Anti-Human LCLAT1 monoclonal antibodyHuman
GM-Tg-rg-IP1072-Ab-1/ GM-Tg-rg-IP1072-Ab-2Anti-Rat LCLAT1 monoclonal antibodyRat
GM-Tg-mg-IP1072-Ab-1/ GM-Tg-mg-IP1072-Ab-2Anti-Mouse LCLAT1 monoclonal antibodyMouse
GM-Tg-cynog-IP1072-Ab-1/ GM-Tg-cynog-IP1072-Ab-2Anti-Cynomolgus/ Rhesus macaque LCLAT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1072-Ab-1/ GM-Tg-felg-IP1072-Ab-2Anti-Feline LCLAT1 monoclonal antibodyFeline
GM-Tg-cang-IP1072-Ab-1/ GM-Tg-cang-IP1072-Ab-2Anti-Canine LCLAT1 monoclonal antibodyCanine
GM-Tg-bovg-IP1072-Ab-1/ GM-Tg-bovg-IP1072-Ab-2Anti-Bovine LCLAT1 monoclonal antibodyBovine
GM-Tg-equg-IP1072-Ab-1/ GM-Tg-equg-IP1072-Ab-2Anti-Equine LCLAT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1072-Ab-1/ GM-Tg-hg-IP1072-Ab-2; GM-Tg-rg-IP1072-Ab-1/ GM-Tg-rg-IP1072-Ab-2;
GM-Tg-mg-IP1072-Ab-1/ GM-Tg-mg-IP1072-Ab-2; GM-Tg-cynog-IP1072-Ab-1/ GM-Tg-cynog-IP1072-Ab-2;
GM-Tg-felg-IP1072-Ab-1/ GM-Tg-felg-IP1072-Ab-2; GM-Tg-cang-IP1072-Ab-1/ GM-Tg-cang-IP1072-Ab-2;
GM-Tg-bovg-IP1072-Ab-1/ GM-Tg-bovg-IP1072-Ab-2; GM-Tg-equg-IP1072-Ab-1/ GM-Tg-equg-IP1072-Ab-2
Products NameAnti-LCLAT1 monoclonal antibody
Formatmab
Target NameLCLAT1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LCLAT1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1072-Ag-1Recombinant multi-species LCLT1/ LCLAT1/ 1AGPAT8 protein
    ORF Viral VectorpGMLP003609human LCLAT1 Lentivirus plasmid
    ORF Viral VectorvGMLP003609human LCLAT1 Lentivirus particle
    ORF Viral VectorpGMLPm002848mouse Lclat1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002848mouse Lclat1 Lentivirus particle


    Target information

    Target IDGM-IP1072
    Target NameLCLAT1
    Gene ID253558,225010,362702,704859,483023,101090183,520912,100070805
    Gene Symbol and Synonyms1-AGPAT 8,1AGPAT8,AGPAT8,ALCAT1,Gm91,HSRG1849,LCLAT1,LPLAT6,LYCAT,RGD1565906,UNQ1849
    Uniprot AccessionQ6UWP7
    Uniprot Entry NameLCLT1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000172954
    Target ClassificationN/A

    The target: LCLAT1, gene name: LCLAT1, also named as 1AGPAT8, AGPAT8, ALCAT1, HSRG1849, LYCAT, UNQ1849. Enables 1-acylglycerol-3-phosphate O-acyltransferase activity. Predicted to be involved in phosphatidylinositol acyl-chain remodeling. Located in cytosol and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.